Director/PDMR Shareholding

RNS Number : 5922Q

Dechra Pharmaceuticals PLC

30 November 2016

 

30 November 2016

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Sale of shares:

Dechra Pharmaceuticals PLC announces that on 30 November 2016, Ian Page and Tony Griffin sold the shares set out below (acquired pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan exercise announced on 29 November 2016) in order to fund the resulting tax liability.   

Name	Capacity	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director/PDMR	58,633	£12.80	817,908	0.879%
Tony Griffin	Director/PDMR	17,133	£12.92	52,104	0.056%

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £12.80	Volume(s) 58,633
d)	Aggregated information -   Aggregate volume -   Price	N/A
e)	Date of the transaction	2016.11.30
f)	Place of the transaction	London Stock Exchange

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Tony Griffin
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	N/A
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB009633180
b)	Nature of the transaction	Partial sale of shares obtained under the Company's Long Term Incentive Plan to satisfy tax liability
c)	Price(s) and volumes(s)	Price(s) £12.92	Volume(s) 17,133
d)	Aggregated information -   Aggregate volume -   Price	N/A
e)	Date of the transaction	2016.11.30
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Suzana Cross, General Counsel and Company Secretary                 

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHAKKDKPBDDNDN